Geron Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.26

+0.03 (+2.44%)

As of Jun 21, 10:13 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 75%

Hold 2 17%

Sell 1 8%

Price Target

Analyst Price Target +1,408.7% upside

Low Target $12.94

Average Target $19.01

High Target $24.33

Current Price $1.26

Current
$1.26

Target
$19.01

$12.94 $19.01 avg $24.33

Scenario Analysis

Bear Case

$12.94

927.0%

Low target

Base Case

$19.01

+1,408.7%

Avg target

Bull Case

$24.33

+1,831.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.01

-37.3% from high

52-Week Low

$1.04

+21.2% from low

Target vs 52W High

$19.01

+845.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%